Cargando…
Drug-Diagnostics Co-Development in Oncology
Developments in genomics are providing a biological basis for the heterogeneity of clinical course and response to treatment that have long been apparent to clinicians. The ability to molecularly characterize human diseases presents new opportunities to develop more effective treatments and new chal...
Autor principal: | Simon, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870296/ https://www.ncbi.nlm.nih.gov/pubmed/24392354 http://dx.doi.org/10.3389/fonc.2013.00315 |
Ejemplares similares
-
Drug-Diagnostics Co-Development in Oncology
por: Jørgensen, Jan Trøst
Publicado: (2014) -
Medical Oncology or Surgical Oncology: Which Branch Should Be Started in Esophageal Cancer Diagnostic Evaluation?
por: Yıldırım, Özgen Ahmet, et al.
Publicado: (2022) -
Editorial: Reshaping the diagnostic process in oncology: science versus technology
por: Grizzi, Fabio, et al.
Publicado: (2023) -
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
por: Yap, Timothy A., et al.
Publicado: (2022) -
Editorial: Next Generation Sequencing Based Diagnostic Approaches in Clinical Oncology
por: Buzdin, Anton, et al.
Publicado: (2021)